Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00333502 Information provided by Cerulean Pharma Inc.

First Received: June 1, 2006 Last Updated: February 8, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2012
Estimated Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)